BTAI
Bioxcel Therapeutics·NASDAQ
--
--(--)
--
--(--)
2.30 / 10
Underperform
Technical analysis is poor, with a score of 2.3/10. Dominant bearish signals include the MACD Death Cross and frequent long upper/lower shadows, suggesting ongoing selling pressure and lack of bullish conviction. The pattern of recent indicators (e.g., MACD Death Cross on Jan 23) reinforces a weak near-term outlook.
Analysis Checks(0/3)
Long Lower Shadow
Score1/10
Win Rate32.91%
Hist. Signals79
Avg Return0.02%
Score1/10
Win Rate32.91%
Hist. Signals79
Avg Return0.02%
MACD Death Cross
Score2.86/10
Win Rate37.50%
Hist. Signals8
Avg Return2.37%
Score2.86/10
Win Rate37.50%
Hist. Signals8
Avg Return2.37%
Long Upper Shadow
Score3.04/10
Win Rate43.59%
Hist. Signals78
Avg Return5.52%
Score3.04/10
Win Rate43.59%
Hist. Signals78
Avg Return5.52%
Long Lower Shadow
Score1/10
Win Rate32.91%
Hist. Signals79
Avg Return0.02%
Score1/10
Win Rate32.91%
Hist. Signals79
Avg Return0.02%
Long Upper Shadow
Score3.04/10
Win Rate43.59%
Hist. Signals78
Avg Return5.52%
Score3.04/10
Win Rate43.59%
Hist. Signals78
Avg Return5.52%
MACD Death Cross
Score2.86/10
Win Rate37.50%
Hist. Signals8
Avg Return2.37%
Score2.86/10
Win Rate37.50%
Hist. Signals8
Avg Return2.37%
What is the current technical signals for BTAI?
- BTAI presents a Underperform setup with a Technical Score of 2.30/10. Key technical indicators highlight an RSI of 36.74 and a MACD of -0.07, with the trend anchored by the 50-Day SMA at 1.84. Traders should monitor key support at 1.32 and resistance at 1.46.
